Antiphospholipid Syndrome and Libman-Sacks Endocarditis in a Bioprosthetic Mitral Valve

The Annals of Thoracic Surgery
Eric H Sladek, Kevin D Accola

Abstract

This report describes one the first cases of antiphospholipid syndrome and Libman-Sacks endocarditis in a bioprosthetic valve. A redo mitral valve replacement was carried out owing to early deterioration of the prior valve. Initially it was considered secondary to rheumatic heart disease; however, pathology analysis and autoimmune workup revealed antiphospholipid syndrome with Libman-Sacks endocarditis. We believe certain populations with mitral valve stenosis may have an underlying antiphospholipid syndrome. As a result, there needs to be a lower threshold for identifying this disease.

References

May 1, 1985·Stroke; a Journal of Cerebral Circulation·J G D'AltonG R Kraag
Mar 5, 2013·Current Rheumatology Reports·Stéphane ZuilyDenis Wahl
Sep 14, 2013·JACC. Cardiovascular Imaging·Carlos A RoldanKendall Crookston

❮ Previous
Next ❯

Citations

Nov 11, 2017·BMJ Case Reports·Jeremy Fleri SolerCecilia Mercieca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris
M TubianaS de Séze
© 2022 Meta ULC. All rights reserved